Search research articles
Contact Us
Filters
Showing results (21-30 of 51) with videos related to
Page
of 6
Sort By:
Scientific Reports
|
August 3, 2021
A cardiovascular magnetic resonance imaging-based pilot study to assess coronary microvascular disease in COVID-19 patients
Stefanos Drakos, Grigorios Chatzantonis, Michael Bietenbeck, et al.
Journal of Thoracic Disease
|
July 10, 2020
Tumor infiltrating T cells influence prognosis in stage I-III non-small cell lung cancer
Arik Bernard Schulze, Georg Evers, Dennis Görlich, et al.
Transplantation and Cellular Therapy
|
April 28, 2021
Fluorodeoxyglucose F 18 for the Assessment of Acute Intestinal Graft-versus-Host Disease and Prediction of Response to Immunosuppressive Therapy
Wolfgang Roll, Georg Evers, Rebecca Strotmann, et al.
Canadian Respiratory Journal
|
June 23, 2020
Alpha-1 Antitrypsin Deficiency and Pulmonary Morbidity in Patients with Primary Immunodeficiency Disease: A Single-Center Experience
Georg Evers, Arik Bernard Schulze, Michael Thrull, et al.
Annals of Hematology
|
September 25, 2013
Visceral leishmaniasis clinically mimicking lymphoma
Georg Evers, Michele Pohlen, Wolfgang E Berdel, et al.
International Journal of Hematology
|
August 1, 2008
Activation of Wnt signaling in cKit-ITD mediated transformation and imatinib sensitivity in acute myeloid leukemia
Lara Tickenbrock, Sina Hehn, Bülent Sargin, et al.
Journal of Extracellular Vesicles
|
March 7, 2024
PD-L1 on large extracellular vesicles is a predictive biomarker for therapy response in tissue PD-L1-low and -negative patients with non-small cell lung cancer
Nadja Schöne, Marcel Kemper, Kerstin Menck, et al.
BMC Cancer
|
September 11, 2021
<sup>18</sup>F-FDG-PET-MRI for the assessment of acute intestinal graft-versus-host-disease (GvHD)
Wolfgang Roll, Philipp Schindler, Max Masthoff, et al.
Oncotarget
|
September 22, 2021
Polyclonal on- and off-target resistance mutations in an <i>EML4-ALK</i> positive non-small cell lung cancer patient under ALK inhibition
Marcel Kemper, Georg Evers, Arik Bernard Schulze, et al.
Oncotarget
|
November 7, 2022
Addendum: Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition
Marcel Kemper, Georg Evers, Arik Bernard Schulze, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 51) with videos related to
Sort By:
Page
of 6
Scientific Reports
|
August 3, 2021
A cardiovascular magnetic resonance imaging-based pilot study to assess coronary microvascular disease in COVID-19 patients
Stefanos Drakos, Grigorios Chatzantonis, Michael Bietenbeck, et al.
Journal of Thoracic Disease
|
July 10, 2020
Tumor infiltrating T cells influence prognosis in stage I-III non-small cell lung cancer
Arik Bernard Schulze, Georg Evers, Dennis Görlich, et al.
Transplantation and Cellular Therapy
|
April 28, 2021
Fluorodeoxyglucose F 18 for the Assessment of Acute Intestinal Graft-versus-Host Disease and Prediction of Response to Immunosuppressive Therapy
Wolfgang Roll, Georg Evers, Rebecca Strotmann, et al.
Canadian Respiratory Journal
|
June 23, 2020
Alpha-1 Antitrypsin Deficiency and Pulmonary Morbidity in Patients with Primary Immunodeficiency Disease: A Single-Center Experience
Georg Evers, Arik Bernard Schulze, Michael Thrull, et al.
Annals of Hematology
|
September 25, 2013
Visceral leishmaniasis clinically mimicking lymphoma
Georg Evers, Michele Pohlen, Wolfgang E Berdel, et al.
International Journal of Hematology
|
August 1, 2008
Activation of Wnt signaling in cKit-ITD mediated transformation and imatinib sensitivity in acute myeloid leukemia
Lara Tickenbrock, Sina Hehn, Bülent Sargin, et al.
Journal of Extracellular Vesicles
|
March 7, 2024
PD-L1 on large extracellular vesicles is a predictive biomarker for therapy response in tissue PD-L1-low and -negative patients with non-small cell lung cancer
Nadja Schöne, Marcel Kemper, Kerstin Menck, et al.
BMC Cancer
|
September 11, 2021
<sup>18</sup>F-FDG-PET-MRI for the assessment of acute intestinal graft-versus-host-disease (GvHD)
Wolfgang Roll, Philipp Schindler, Max Masthoff, et al.
Oncotarget
|
September 22, 2021
Polyclonal on- and off-target resistance mutations in an <i>EML4-ALK</i> positive non-small cell lung cancer patient under ALK inhibition
Marcel Kemper, Georg Evers, Arik Bernard Schulze, et al.
Oncotarget
|
November 7, 2022
Addendum: Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition
Marcel Kemper, Georg Evers, Arik Bernard Schulze, et al.
Page
of 6